Jacques BONNETERRE
Centre Oscar Lambret · Oscar Lambret Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jacques BONNETERRE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:37 UTC. Open this list on ClinicalTrials.gov
- N/ANCT01780064 · Psychosocial Support to Facilitate the Return to Employment of Women With Breast CancerCentre Oscar Lambret · terminated · Breast Cancer · study director
- Ph2NCT01658462 · Phase II Study of Docetaxel +/- Nintedanib in Breast CancerCentre Oscar Lambret · completed · Breast Cancer · study director
- N/ANCT00959556 · Study of Blood Samples in Patients With Breast CancerCentre Oscar Lambret · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:37 UTC. The ranking covers the 200 most relevant of 86 PubMed records, and a shared surname and initials can bring in a namesake. All 86 on PubMed
- 632 citationsRCR 13.7
- Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.J Clin Oncol · 2006431 citationsRCR 9.7
- Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.Cancer · 2001429 citationsRCR 10.0
- Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.J Clin Oncol · 1997420 citationsRCR 11.8
- Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.J Clin Oncol · 2004373 citationsRCR 7.9
- Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.J Clin Oncol · 1996344 citationsRCR 9.5
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).Lancet Oncol · 2014309 citationsRCR 7.2
- 205 citationsRCR 6.2
- 197 citationsRCR 5.3
- Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results.Eur J Cancer · 2003132 citationsRCR 2.9